Atika Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-73,000	Closed	-$6.1M	–	104
2024 Q4	$6.1M	Sell	73,000 -10,000	-12%	-$822K	0.65%	56
2024 Q3	$6.07M	Sell	83,000 -14,500	-15%	-$1.09M	0.62%	50
2024 Q2	$6.68M	Sell	97,500 -7,500	-7%	-$520K	0.65%	52
2024 Q1	$7.27M	Buy	105,000 +5,000	+5%	+$344K	0.72%	54
2023 Q4	$7.16M	Buy	100,000 +14,100	+16%	+$811K	0.96%	44
2023 Q3	$4.47M	Sell	85,900 -7,000	-8%	-$408K	0.59%	57
2023 Q2	$5.88M	Buy	92,900 +39,900	+75%	+$2.49M	0.59%	57
2023 Q1	$2.87M	Sell	53,000 -66,000	-55%	-$3.19M	0.42%	60
2022 Q4	$6.3M	Sell	119,000 -44,900	-27%	-$2.25M	0.91%	41
2022 Q3	$7.63M	Sell	163,900 -85,100	-34%	-$4.45M	0.65%	60
2022 Q2	$14.2M	Buy	249,000 +39,000	+19%	+$2.21M	1.6%	22
2022 Q1	$12.8M	Buy	+210,000	New	+$10.9M	1.08%	38